Classification and biology of astrocytic gliomas.
The presented classification of astrocytic gliomas follows the system adopted by the WHO which was last published in 1993. The nosographic position of each tumour type is discussed in relation to previous positions and the rationale of changes is provided. The biology and pathology of anaplasia, leading from astrocytoma to glioblastoma, are discussed briefly. The increasing genotypic and phenotypic heterogeneity is described in its progressive stages. A series of genetic changes are associated with the main histologic features of malignancy , such as TP53 mutations, EGFR amplification, CDKN2 deletion, etc. The genetic differences between primary and secondary glioblastomas are emphasised. Tumour-associated biological events are presented: cell invasion and spread, necrosis and apoptosis and angiogenesis are all discussed in some detail. Of each event a short survey on the principal phenotypic and molecular features is given with emphasis on their significance to pathogenesis. Each tumour type is briefly summarised from epidemiological, clinical and pathological standpoints.
Schiffer
D
D
Department of Neuroscience, University of Turin, Italy.
D000708:Anaplasia / Q000145:classification / Q000235:genetics / Q000473:pathology; D001254:Astrocytoma / Q000145:classification* / Q000235:genetics / Q000473:pathology; D001932:Brain Neoplasms / Q000145:classification* / Q000235:genetics / Q000473:pathology; D006801:Humans; D009857:Oncogenes / Q000235:genetics; D014944:World Health Organization